Page last updated: 2024-10-28

lidocaine and Alstrom Syndrome

lidocaine has been researched along with Alstrom Syndrome in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Alstrom Syndrome: Rare autosomal recessive disease characterized by multiple organ dysfunction. The key clinical features include retinal degeneration (NYSTAGMUS, PATHOLOGIC; RETINITIS PIGMENTOSA; and eventual blindness), childhood obesity, sensorineural hearing loss, and normal mental development. Endocrinologic complications include TYPE 2 DIABETES MELLITUS; HYPERINSULINEMIA; ACANTHOSIS NIGRICANS; HYPOTHYROIDISM; and progressive renal and hepatic failures. The disease is caused by mutations in the ALMS1 gene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Werdehausen, R1
Braun, S1
Essmann, F1
Schulze-Osthoff, K1
Walczak, H1
Lipfert, P1
Stevens, MF1

Other Studies

1 other study available for lidocaine and Alstrom Syndrome

ArticleYear
Lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling.
    Anesthesiology, 2007, Volume: 107, Issue:1

    Topics: Alstrom Syndrome; Anesthetics, Local; Apoptosis; Blotting, Western; CASP8 and FADD-Like Apoptosis Re

2007